Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions

NCT01017185 is registered in ClinicalTrials.gov with Takara Bio Inc. as lead sponsor.

NCT NCT01017185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01017185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Lead sponsor
Takara Bio Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2009
Completion date
March 31, 2015
Enrollment
28 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma of the breast, malignant melanoma, refractory head and neck cancer, squamous cell carcinoma, skin